A Phase 1 of CTX-8371 in Patients With Advanced Malignancies
Compass Therapeutics
Compass Therapeutics
Mayo Clinic
OHSU Knight Cancer Institute
Celgene
University of Wisconsin, Madison
Wake Forest University Health Sciences
Incyte Corporation
Masonic Cancer Center, University of Minnesota
University of Louisville
Memorial Sloan Kettering Cancer Center
Valerio Therapeutics
National Cancer Institute (NCI)
Indiana University
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Novartis
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Case Comprehensive Cancer Center